These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 6200948

  • 21. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets.
    Menys VC, Davies JA.
    Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
    Saniabadi AR, Lowe GD, Belch JJ, Forbes CD, Prentice CR, Barbenel JC.
    Thromb Haemost; 1983 Oct 31; 50(3):718-21. PubMed ID: 6196854
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
    Whittle BJ, Moncada S, Whiting F, Vane JR.
    Prostaglandins; 1980 Apr 31; 19(4):605-27. PubMed ID: 6992234
    [Abstract] [Full Text] [Related]

  • 26. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs.
    Mackie IJ, Jones R, Machin SJ.
    J Clin Pathol; 1984 Aug 31; 37(8):874-8. PubMed ID: 6206096
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of platelet aggregation by a new agent, 5-(Z,E)-13,14-didehydro-20-methyl-carbo PGI2 (FCE 22509).
    Bergamaschi M, Pierucci L, Ferti C, Corsi G, Branzoli U, Mandelli V.
    Prostaglandins Leukot Med; 1984 Oct 31; 16(1):19-27. PubMed ID: 6393142
    [Abstract] [Full Text] [Related]

  • 28. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
    Kanayama T, Kimura Y, Iseki K, Hayashi Y, Tamao Y, Mizogami S.
    J Pharmacol Exp Ther; 1990 Dec 31; 255(3):1210-7. PubMed ID: 1702154
    [Abstract] [Full Text] [Related]

  • 29. Preservation of platelet function in cryopreserved platelet concentrates with prostacyclin.
    Johnson EJ, Mackie IJ, Machin SJ, Brozović B.
    Clin Lab Haematol; 1984 Dec 31; 6(2):141-4. PubMed ID: 6207975
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cardiovascular and antithrombotic effects of ZK 96 480, a novel metabolically stable carbacyclin derivative with oral activity.
    Stürzebecher CS, Loge O, Schröder G, Müller B, Witt W.
    Prog Clin Biol Res; 1987 Dec 31; 242():425-31. PubMed ID: 3313417
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R, Grossoni M, Ukmar G, Colombo M, Mongelli N.
    Prostaglandins Leukot Med; 1986 Mar 31; 21(3):231-45. PubMed ID: 3517883
    [Abstract] [Full Text] [Related]

  • 36. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D, de Nucci G, Vane JR.
    Thromb Haemost; 1991 Apr 08; 65(4):421-4. PubMed ID: 1647553
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat.
    Stürzebecher S, Haberey M, Müller B, Schillinger E, Schröder G, Skuballa W, Stock G, Vorbrüggen H, Witt W.
    Prostaglandins; 1986 Jan 08; 31(1):95-109. PubMed ID: 3513260
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.